Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,402,182
+$99,065 QoQ
Shares Held
13,396
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.69%
of 13F equity value
Holder Rank
#1,904
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Wealth Partners, LLC holds $8,124,213 across 7 Drug Manufacturers - General names. JNJ ranks #1 (41.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
13,396 | $3,402,182 | |
| 2 | MRK |
Merck & Co., Inc.
|
15,653 | $2,011,410 | |
| 3 | ABBV |
AbbVie Inc.
|
3,699 | $930,816 | |
| 4 | PFE |
Pfizer Inc
|
21,656 | $521,476 | |
| 5 | AMGN |
Amgen Inc
|
1,372 | $496,828 | |
| 6 | LLY |
ELI LILLY & Co
|
331 | $397,011 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,885 | $364,490 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,402,182 | 13,396 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,303,117 | 13,513 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,223,056 | 10,742 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,994,748 | 10,758 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,533,915 | 10,042 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,675,149 | 10,101 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,506,940 | 10,420 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,623,517 | 10,018 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,462,623 | 10,007 | Shares | Sole | 2024-09-11 | |
| 2024-03-31 | $1,573,357 | 9,946 | Shares | Sole | 2024-09-11 | |
| 2023-12-31 | $1,558,152 | 9,941 | Shares | Sole | 2024-09-11 | |
| 2023-09-30 | $1,551,425 | 9,961 | Shares | Sole | 2024-09-11 | |
| 2023-06-30 | $1,511,032 | 9,129 | Shares | Sole | 2024-09-11 | |
| 2023-03-31 | $1,486,915 | 9,593 | Shares | Sole | 2024-09-11 | |
| 2022-12-31 | $1,712,091 | 9,692 | Shares | Sole | 2024-09-11 | |
| 2022-09-30 | $1,611,709 | 9,866 | Shares | Sole | 2024-09-11 | |
| 2022-06-30 | $1,802,081 | 10,152 | Shares | Sole | 2024-09-11 | |
| 2022-03-31 | $1,861,269 | 10,502 | Shares | Sole | 2024-09-11 | |
| 2021-12-31 | $1,765,100 | 10,318 | Shares | Sole | 2024-09-10 | |
| 2021-09-30 | $1,686,544 | 10,443 | Shares | Sole | 2024-09-10 | |
| 2021-06-30 | $1,722,191 | 10,454 | Shares | Sole | 2024-09-10 | |
| 2021-03-31 | $1,679,821 | 10,221 | Shares | Sole | 2024-09-10 | |
| 2020-12-31 | $1,632,030 | 10,370 | Shares | Sole | 2024-09-10 | |
| 2020-09-30 | $1,543,885 | 10,370 | Shares | Sole | 2024-09-10 | |
| 2020-06-30 | $1,464,802 | 10,416 | Shares | Sole | 2024-09-10 | |
| 2020-03-31 | $1,359,818 | 10,370 | Shares | Sole | 2024-09-10 | |
| No filing history on record for this holder in this stock. | ||||||